Comprehensive Diagnosis of Mantle Cell Lymphoma.
10.19746/j.cnki.issn.1009-2137.2023.06.018
- Author:
Hui YANG
1
;
Rui GUO
1
;
Yu SHI
1
;
Rong WANG
1
;
Chun QIAO
1
;
Yu-Jie WU
1
;
Lei FAN
1
;
Wei XU
1
;
Jian-Yong LI
1
;
Hai-Rong QIU
2
Author Information
1. Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
2. Department of Hematology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China,E-mail: qiuqiu1203@sina.com.
- Publication Type:Journal Article
- Keywords:
compre-hensive diagnosis;
leukemic non-lymph node mantle cell lymphoma;
mantle cell lymphoma
- MeSH:
Adult;
Humans;
Lymphoma, Mantle-Cell/genetics*;
Bone Marrow/pathology*;
Leukemia/pathology*;
Mutation;
Immunophenotyping
- From:
Journal of Experimental Hematology
2023;31(6):1720-1725
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the value of multiple detection methods based on histopathology and supplemented by bone marrow or peripheral blood sample detections in the comprehensive diagnosis of mantle cell lymphoma (MCL).
METHODS:The clinical, immunophenotypic, pathologic, cytogenetic and molecular features of 153 newly diagnosed MCL patients admitted to the hematology department of our hospital from May 2009 to September 2022 were analyzed.
RESULTS:144 (96.6%) of the 149 MCL patients who underwent marrow or peripheral blood IGH/CCND1 FISH detection at initial diagnosis were positive, of which 36 cases (24.2%) had a low proportion positive. The immunophenotypes in 115 patients were analyzed by flow cytometry (FCM), 89 cases (77.4%) conformed to MCL while 23 cases (20.0%) were initially diagnosed as B-cell lymphoproliferative disorders (B-LPD). Of the 75 cases who performed bone marrow biopsy, 50 cases (66.7%) had morphological and immunophenotypic characteristics consistent with MCL, 15 cases (20.0%) were classified as B-LPD, and 10 cases with no obvious abnormality. 77 patients underwent histopathology examination, of which 73 cases (94.8%) had typical clinicopathological features of MCL, including 2 CCND1 negative MCL, 2 pleomorphic variants, 5 pleomorphic variants and 4 cases diagnosed as other leukemia or lymphoma. Among 153 cases of MCL, 128 cases were classic MCL(cMCL), and another 25 cases (16.3%) were diagnosed as leukemic non-lymph node MCL (lnnMCL). The incidence of IGHV mutation, TP53 mutation and CD23 expression positive were significantly different between cMCL and lnnMCL.
CONCLUSION:Histopathology is still the main standard for the diagnosis of cMCL, and detection based on bone marrow or peripheral blood samples is an important means for the diagnosis of lnnMCL. Single marker or examination can cause a certain proportion of misdiagnosis. The accurate diagnosis of MCL depends on a combination of multiple detection methods.
